Platelets, in fact, play a key role in atherogenesis, and its thrombotic complications and measures, which lead to blockade of one or multiple pathways modulating platelet activation and aggregation processes, are pivotal in reducing ischemic risk in diabetic subjects (4).
For this reason, interventions to block one or multiple pathways modulating platelet activation and aggregation processes are considered as an essential component of diabetes care to reduce ischemic risk (4).
In conclusion, our work is the first demonstration that the protein Dab2, a platelet aggregation inhibitor, specifically binds to sulfatides and that this interaction modulates the progression of platelet activation.
We found that the N-terminal region of Dab2 specifically binds sulfatides through two conserved polybasic motifs, and this association partitions the protein into two pools at the platelet surface, the sulfatide- and integrin receptor-bound states, thus, modulating the extent of platelet activation.
Our previous work has revealed the unexpected finding that GR activation can modulate platelet function [10].
Resveratrol also prevents platelet activation by modulating platelet adhesion, secretion and activation signaling, ROS production, and apoptosis and by enhancing nitric oxide (NO) production [ 20– 20].
Platelet activity was assessed using platelet activation markers (CD62P and CD63).
By upregulating platelet activation, P-selectin modulates consequences of chronic type 2 cytokine mediated inflammation.
We investigated the involvement of recently identified mechanisms of complement activation during platelet activation [9]-[11] in collagen-activated platelet.
Consideration of these factors leads to the summary that (i) acute, strenuous exercise can lead to platelet activation, (ii) regular physical activity and/or physical fitness diminish or prevent platelet activation in response to acute exercise, and (iii) habitual physical activity and/or physical fitness also favorably modulate platelet function at physical rest.
